2022 年 4 巻 1 号 p. 70-71
The authors apologize for the written mistakes in the Result sections. Corrections are shown below.
1) From Page 507, Line 21 to Page 508, Line 2
Incorrect:
The volume of the thrombus (amount of protein) around stent struts was lowest in the Triple group, followed by the Prasugrel+OAC and conventional DAPT groups, and was highest in the Control group (median [IQR] 0.49 [0.38–1.11], 0.74 [0.46–1.34], 0.96 [0.50–1.41], 2.92 [2.14–4.24], and 3.72 [2.30–5.15] mg/mL in the Triple, Prasugrel+OAC, Conventional DAPT, Aspirin+OAC, and Control groups, respectively; Figure 4; Table 1).
Correct:
The volume of the thrombus (amount of protein) around stent struts was lowest in the Triple group, followed by the Prasugrel+OAC and conventional DAPT groups, and was highest in the Control group (median [IQR] 0.49 [0.38–1.11], 0.74 [0.46–1.34], 0.96 [0.50–1.41], 2.92 [2.14–4.24], and 3.73 [2.30–5.15] mg/mL in the Triple, Prasugrel+OAC, Conventional DAPT, Aspirin+OAC, and Control groups, respectively; Figure 4; Table 1).
2) Page 508, Table 1
Group 1 vs. Group 2 | Thrombus volume: Group 1 vs. Group 2 (mg/mL) |
P value |
---|---|---|
Control vs. Triple | 3.73 vs. 0.49 | 0.003 |
Control vs. Prasugrel+OAC | 3.73 vs. 0.74 | 0.005 |
Control vs. DAPT | 3.73 vs. 0.96 | 0.007 |
Control vs. Aspirin+OAC | 3.73 vs. 2.92 | 0.9 |
Triple vs. Prasugrel+OAC | 0.49 vs. 0.74 | 0.99 |
Triple vs. DAPT | 0.49 vs. 0.96 | 0.99 |
Triple vs. Aspirin+OAC | 0.49 vs. 2.92 | 0.02 |
Prasugrel+OAC vs. DAPT | 0.74 vs. 0.96 | 0.99 |
Prasugrel+OAC vs. Aspirin+OAC | 0.74 vs. 2.92 | 0.03 |
DAPT vs. Aspirin+OAC | 0.96 vs. 2.92 | 0.04 |
DAPT, dual antiplatelet therapy; OAC, oral anticoagulant; Triple, treatment with prasugrel, aspirin, and warfarin.
3) Page 508, Table 2
Group 1 vs. Group 2 | Bleeding time: Group 1 vs. Group 2 (s) |
P value |
---|---|---|
Control vs. Triple | 210 vs. 900 | 0.08 |
Control vs. Prasugrel+OAC | 210 vs. 345 | 0.99 |
Control vs. DAPT | 210 vs. 270 | 0.99 |
Control vs. Aspirin+OAC | 210 vs. 405 | 0.99 |
Triple vs. Prasugrel+OAC | 900 vs. 345 | 0.1 |
Triple vs. DAPT | 900 vs. 270 | 0.04 |
Triple vs. Aspirin+OAC | 900 vs. 405 | 0.2 |
Prasugrel+OAC vs. DAPT | 345 vs. 270 | 0.99 |
Prasugrel+OAC vs. Aspirin+OAC | 345 vs. 405 | 0.99 |
DAPT vs. Aspirin+OAC | 270 vs. 405 | 0.9 |
DAPT, dual antiplatelet therapy; OAC, oral anticoagulant; Triple, treatment with prasugrel, aspirin, and warfarin.